Total Visits

Views
A randomized phase II study with two schedules of the novel indoloquinone EO9 in non-small-cell lung cancer: A study of the EORTC early clinical studies group (ECSG)116

Total Visits Per Month

Νοέμβριος 2023Δεκέμβριος 2023Ιανουάριος 2024Φεβρουάριος 2024Μάρτιος 2024Απρίλιος 2024Μάϊος 2024
A randomized phase II study with two schedules of the novel indoloquinone EO9 in non-small-cell lung cancer: A study of the EORTC early clinical studies group (ECSG)01721110

Top country views

Views
Πολωνία52
Ηνωμένες Πολιτείες52
Γαλλία3
Ιρλανδία2
Γερμανία1
EU1
Ελλάδα1
Ρωσία1
Σουηδία1
Τόγκο1

Top cities views

Views
Warsaw52
Louisville11
Boardman10
Des Moines9
San Ramon8
Ann Arbor5
Dublin2
Fairfield2
Ashburn1
Athens1